Skip to content

PTHS PTHS Net margin

Net margin at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-17.6%-103pp
Journey Medical Corporation logo
Journey Medical CorporationDERM
-14.8%
Opko Health logo
Opko HealthOPK
-36.6%-44.8pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
101.6%+60.1pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
104.3%+71.4pp
HRO
HarrowHROW
-19.8%+18.0pp

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Calculated from PTHS’s reported figures.

Based on trailing twelve months.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's net margin?
PTHS (PTHS) reported net margin of -186.2% in Q1 2026.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.